Effect of zoledronic acid (ZA) versus placebo on bone mineral density (BMD) in androgen-deprived prostate cancer patients with and without bone metastases (mets)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4760-4760
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4760-4760
Keyword(s):
Keyword(s):
2019 ◽
Vol 105
(1)
◽
pp. E312-E313
Keyword(s):
Keyword(s):
2019 ◽
Vol 51
(4)
◽
pp. 607-614
◽
Keyword(s):